Clinical trial
Safety and Efficacy of Subintimal Versus Intraluminal Approach for Atherosclerotic Chronic Occlusive Femoro-Popliteal Arterial Disease: Prospective, Multicenter, Randomized, Controlled Trial (SCENARIO-FP)
NCT02544555 is registered in ClinicalTrials.gov with Korea University Guro Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Safety and Efficacy of Subintimal Versus Intraluminal Approach for Atherosclerotic Chronic Occlusive Femoro-Popliteal Arterial Disease: Prospective, Multicenter, Randomized, Controlled Trial (SCENARIO-FP)
- Lead sponsor
- Korea University Guro Hospital
- Phase
- Not applicable
- Overall status
- Unknown status
- Start date
- May 31, 2014
- Completion date
- May 31, 2022
- Enrollment
- 200 (estimated)
- Sites
- 3
Conditions
As the registry lists them; a condition with its own page is linked.